Cargando…
A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma
A single 9-MeV electron treatment, following invasive thoracic procedures in patients with malignant pleural mesothelioma, was examined. In all, 58 sites were randomised to prophylactic radiotherapy or not. There was no statistically significant difference in tract metastasis. A single 10-Gy treatme...
Autores principales: | Bydder, S, Phillips, M, Joseph, D J, Cameron, F, Spry, N A, DeMelker, Y, Musk, A W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364745/ https://www.ncbi.nlm.nih.gov/pubmed/15199394 http://dx.doi.org/10.1038/sj.bjc.6601957 |
Ejemplares similares
-
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014) -
Prophylactic procedure tract radiotherapy for malignant pleural mesothelioma: A systematic review and meta-analysis
por: Bergamin, Sarah, et al.
Publicado: (2018) -
Protocol for the surgical and large bore procedures in malignant pleural mesothelioma and radiotherapy trial (SMART Trial): an RCT evaluating whether prophylactic radiotherapy reduces the incidence of procedure tract metastases
por: Clive, Amelia O, et al.
Publicado: (2015) -
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
por: Clive, Amelia O, et al.
Publicado: (2016) -
Skin metastasis of malignant mesothelioma()()
por: Mori, Tatsuhiko, et al.
Publicado: (2021)